Watch Ticker

Protagonist Therapeutics, Inc

Go to Protagonist Therapeutics, Inc Website

$26.09

(%)

Live

Previous Close

$26.09

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.5 billion USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy

Protagonist Therapeutics (PTGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Related tickers: PTGX.

Read Full Article

Zacks Equity Research - Wall Street Analysts Think Protagonist Therapeutics (PTGX) Could Surge 48.38%: Read This Before Placing a Bet

The consensus price target hints at a 48.4% upside potential for Protagonist Therapeutics (PTGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Related tickers: PTGX.

Read Full Article

Trending Tickers

LASE

XNAS

$2.04

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.58

(%)

XNYS

$69.47

(%)

MLGO

XNAS

$0.00

(%)